Sioux Falls, SD — Sharing data has been a sensitive subject in healthcare, but with companies and consumers becoming more willing to share data has drastically changed the way that we operate on a daily basis. The social and human services sector has been lagging behind in this arena, but a company called Face It TOGETHER is looking to change that.

Their aim is to understand how recovery impacts a person and society as a whole. The company has developed a proprietary, HIPAA compliment care management system that allows care service providers to connect with people in recovery in real time and monitor their recovery plan. While remote monitoring isn’t anything new, this space of addiction care has long avoided digital tools for fear of exposing sensitive data.

Why this matters:

The leveraging of this technology to help improve outcomes can help determine if peer support is helping patients to recover from their addiction. Data is a valuable new tool in the addiction care space that can help justify the costs and measures needed to recover an individual. The Big Data movement isn’t slowing down and now has the opportunity to effect a problem that is estimated to cost taxpayers 700 Billion per year.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.